Odyssey Health, Inc.
ODYY
$0.03
$0.0011.49%
OTC PK
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -59.53% | -51.03% | -79.79% | -77.07% | -54.50% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -60.22% | -52.29% | -79.30% | -76.80% | -52.17% |
| Operating Income | 60.22% | 52.29% | 79.30% | 76.80% | 52.17% |
| Income Before Tax | 8.77% | -106.91% | -228.39% | -239.27% | 69.29% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 8.77% | -106.91% | -228.39% | -239.27% | 69.29% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 8.77% | -106.91% | -228.39% | -239.27% | 69.29% |
| EBIT | 60.22% | 52.29% | 79.30% | 76.80% | 52.17% |
| EBITDA | 76.47% | 52.33% | 79.32% | 76.80% | 52.15% |
| EPS Basic | -367.44% | -324.32% | -213.74% | -226.23% | 108.27% |
| Normalized Basic EPS | 55.78% | 59.57% | 78.99% | 77.85% | 58.24% |
| EPS Diluted | 34.81% | 16.38% | -261.97% | -292.76% | 51.73% |
| Normalized Diluted EPS | 50.00% | 55.56% | 77.50% | 76.62% | 63.07% |
| Average Basic Shares Outstanding | 3.68% | 9.78% | 15.73% | 22.45% | 22.37% |
| Average Diluted Shares Outstanding | -1.67% | 3.77% | 9.07% | 15.00% | 29.03% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |